Menu
Recruiting NCT01048281

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

— Observational Stomach Cancer Gastro-Esophageal(GE) Junction Cancer Gastric (Stomach) Cancer Esophageal Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood draw, Tissue tumor biopsy.
Who it may be relevant to
Registry conditions: Stomach Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastric (Stomach) Cancer, Esophageal Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Interventions

  • Procedure Blood draw
  • Procedure Tissue tumor biopsy

Primary outcome measures

  • p53 activity by routine pathologic analysis [Time frame: time of collection]
  • NER activity by routine pathologic analysis [Time frame: time of collection]

Eligibility criteria

Inclusion criteria

  • Over 18
  • Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Exclusion criteria

  • Under 18
  • No family or personal history of gastric or esophageal cancer

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Stanford University School of Medicine — Stanford

Identifiers

NCT: NCT01048281 · IRB-13473 · 76274 · CA109190 · SU-11022007-787

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗